Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which stroke rehab works best? new trial pits mirror therapy against cognitive training

NCT ID NCT07546864

Symptom relief Sponsor: Hacettepe University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares three rehabilitation approaches for people recovering from a stroke: mirror therapy (using a mirror to trick the brain into thinking the affected limb is moving), cognitive orientation to daily occupational performance (CO-OP, a problem-solving strategy to achieve personal goals), and conventional occupational therapy. All participants also receive robotic balance training. The trial involves 45 adults who are 3 to 12 months post-stroke and have some movement recovery. They will receive therapy for 4 weeks (5 sessions per week) and be followed for 3 months to see which approach best improves motor function, daily activities, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
mirror therapy, cognitive orientation to daily occupational performance (CO-OP), and conventional occupational therapy
What this could lead to
If successful, this study could show which rehabilitation approach works best for improving motor function and daily living skills after a stroke.
What could go wrong
This is a small, early-stage trial with only 45 participants, so results may not apply to everyone. The therapies are behavioral, so individual effort and consistency matter.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 45 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * \- Individuals diagnosed with ischemic or hemorrhagic stroke * Age 18 years and older * Subacute (3-6 months post-stroke) or chronic stage (6-12 months post-stroke) * Brunnstrom Motor Recovery Stage ≥3 for upper extremity, ≥4 for hand, and ≥4 for lower extremity * Mini-Mental State Examination (MMSE) score ≥24 * No severe visual, orthopedic, or additional neurological impairments * Not participating in another study during the research period * Voluntary consent to participate in the study Exclusion Criteria: * \- Poor motor coordination or major medical problems that would prevent participation * Presence of Wernicke's aphasia * Botulinum toxin injection within the last 3 months * Psychiatric conditions that may interfere with participation (e.g., depression, ongoing psychiatric treatment, low motivation)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke Stroke rehabilitaion

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Bayburt State Hospital

    RECRUITING

    Bayburt, Merkez, 69000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.